Vitrakvi 25 mg

Vitrakvi 25 mg is a medicine authorised by Swissmedic under authorisation number 67281. The authorisation holder is Bayer (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 28 May 2020 and the authorisation is limited until 19 February 2029. ATC code L01EX12 places the medicine in the group Antineoplastic agents.

Dispensing category A
Authorisation number 67281
ATC L01EX12
Synthetic medicines

Authorisation data
Authorisation number	67281
Name	Vitrakvi 25 mg
Full name	Vitrakvi 25 mg, Kapseln
Authorisation holder	Bayer (Schweiz) AG
Medicinal product code	Synthetic medicines
Dispensing category	A · Prescription, not repeatable
ATC code	L01EX12
First authorisation	28 May 2020
Authorisation validity	19 February 2029

Strengths
No.	Name	Dispensing category	Authorisation date
1	Vitrakvi 25 mg, Kapseln	A	28 May 2020
2	Vitrakvi 100 mg, Kapseln	A	28 May 2020

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	56	Kapsel(n)	L01EX12	07.16.1.	A
2	56	Kapsel(n)	L01EX12	07.16.1.	A

Scroll the table sideways

Medicines in the same ATC group

Vitrakvi 20 mg/mlAuthorisation number 67282 · Bayer (Schweiz) AG · ATC L01EX12A

Other medicines from this authorisation holder

Adempas 0.5 mgAuthorisation number 62903 · ATC C02KX05B Adempas junior 0.15 mg/mlAuthorisation number 69929 · ATC C02KX05B AleveAuthorisation number 53810 · ATC M01AE02D Alka-SeltzerAuthorisation number 8671 · ATC N02BA01D Ambelvist 0.1 mmol/ mlAuthorisation number 70405 · ATC V08CA13B Ambelvist 0.1 mmol/ mlAuthorisation number 70441 · ATC V08CA13B Ambelvist 0.1 mmol/ nlAuthorisation number 70440 · ATC V08CA13B AngeliqAuthorisation number 56275 · ATC G03FA17B

Frequently asked questions

Is Vitrakvi 25 mg authorised in Switzerland?

Yes. Vitrakvi 25 mg is authorised by Swissmedic under authorisation number 67281, data as of 01 September 2026. The authorisation is limited until 19 February 2029.

Which dispensing category does Vitrakvi 25 mg have?

Vitrakvi 25 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Vitrakvi 25 mg?

The authorisation holder is Bayer (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.